MYCN and medulloblastoma: SOX9 has been reported as a critical transcription factor in MYCN Proto-Oncogene, BHLH Transcription Factor, MYCN-driven medulloblastoma (Swartling et al., 2014) and can be related to drug resistance of these tumors (Rahmanto et al., 2016).